NCT06364033View on ClinicalTrials.gov

Biological and Clinical Efficacy of Shingrix in Patients With CLL

NANot yet recruitingINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

October 31, 2028

Conditions
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL-like MBLVaricella-zoster Virus Reactivation
Interventions
BIOLOGICAL

serologic response evaluation

Blood samples collection

Trial Locations (1)

Unknown

UOC Ematologia ASST dei Sette Laghi, Varese

All Listed Sponsors
lead

Gruppo Italiano Malattie EMatologiche dell'Adulto

OTHER

NCT06364033 - Biological and Clinical Efficacy of Shingrix in Patients With CLL | Biotech Hunter | Biotech Hunter